Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Medical Oncology
How would you approach new dermal mets in a patient who recently finished chemoradiation for head and neck SCC?
Answer from: Radiation Oncologist at Academic Institution
Dermal mets are M1 disease. Since the patient received chemo, (s)he has a medical oncologist who should manage the case moving forward.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Academic Institution
Palliative systemic therapy or supportive care.
Sign In
or
Register
to read more
18773
18774
Related Questions
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?